🌞 Could a simple vitamin supplement dramatically reduce the danger of a second heart attack?
A new clinical trial from Intermountain Health suggests that personalized vitamin D3 supplementation may cut the risk of a repeat heart attack by half among recent survivors.
Researchers enrolled 630 patients who had suffered a heart attack within the past month, most of whom had low vitamin D levels. Instead of prescribing a fixed dose, the study adjusted each individual’s supplementation to maintain their blood levels above 40 ng/mL—often requiring much higher doses than current recommendations.
Over several years of follow-up, the group receiving targeted vitamin D3 had a second heart attack rate of just 3.8%, compared to 7.9% in the control group who did not receive such management. While total major cardiovascular events (including heart failure, stroke, or death) were not reduced, the data highlight how correcting deficiency with tailored dosing can be a game-changer in cardiac care.
These promising findings await confirmation from larger trials, but signal a potential shift toward more individualized, proactive strategies to prevent repeat heart attacks in vulnerable patients.
Follow Science Sphere for regular scientific updates
📄 RESEARCH PAPER
📌 Heidi May et al, "Targeted Vitamin D3 Supplementation Cuts Risk of Second Heart Attack in Half: The TARGET-D Trial," Presented at the American Heart Association Scientific Sessions (2025)
